TB test accepted for ‘exceptional private use’
Actiphage is a six-hour test that can identify the presence of live mycobacteria in blood or milk samples.
A novel test for bovine TB that is more sensitive than previous methods has been accepted for ‘exceptional private use’ in England.
Actiphage is a six-hour test that can identify the presence of live mycobacteria in blood or milk samples. The currently approved skin test for bovine TB assesses the animal’s response to the bacteria and results take 72 hours.
Under the new ‘exceptional private use’ protocol, Actiphage can be used on a small number of large, persistently-infected herds. Before it can be given the go-ahead for veterinary use, however, it will need to go through further trials.
The news has been welcomed by the British Veterinary Association (BVA). BVA president John Fishwick said:
“We welcome any test that could improve the accuracy of diagnosing bovine TB and it is heartening to hear that this new test could potentially provide quicker, more convenient results.
“With any TB test, it is absolutely crucial that its sensitivity, specify and performance are fully understood and it is reassuring that the Animal and Plant Health Agency have authorised the exceptional private use of this test to it will be used appropriately at this stage of its development.
“TB testing is an important tool that can help achieve the long-term goal of TB eradication and must be part of a comprehensive toolkit of measures.”
RCVS Knowledge has called on vet practices to audit their post-operative neutering outcomes.
